Antioxidant nutrients and adriamycin toxicity

被引:291
|
作者
Quiles, JL
Huertas, JR
Battino, M
Mataix, J
Ramírez-Tortosa, MC
机构
[1] Univ Granada, Dept Physiol, Inst Nutr & Food Technol, E-18071 Granada, Spain
[2] Univ Ancona, Fac Med, Inst Biochem, Ancona, Italy
[3] Univ Granada, Dept Biochem & Mol Biol, Inst Nutr & Food Technol, E-18071 Granada, Spain
关键词
vitamin E; vitamin C; vitamin A; carotenoids; coenzyme Q; flavonoids; olive oil; selenium; adriamycin; doxorubicin; antioxidants; toxicity;
D O I
10.1016/S0300-483X(02)00383-9
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The anthracycline antibiotic adriamycin (doxorubicin) is one of the most effective chemotherapeutic agents against a wide variety of cancers. However, its use is seriously limited by the development in the heart of acute and chronic toxic effects. Mechanisms of action and toxicity of adriamycin are briefly revised in this review. Among followed strategies to attenuate adriamycin toxicity are dosage optimisation. synthesis and use of analogues or combined therapy with antioxidants. The most promising results come from the combination of the drug delivery together with an antioxidant in order to reduce oxidative stress. Many antioxidants have been assayed with very different results. Among these molecules, metal ions chelators and low-molecular-mass agents that scavenge reactive oxygen species and that are synthesised in vivo have been widely studied. However, the present review will be exclusively focused on the antioxidants that are derived from the diet, in particular the role of vitamin E, vitamin C, vitamin A, coenzyme Q, flavonoids, antioxidant components of virgin olive oil and selenium. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:79 / 95
页数:17
相关论文
共 50 条
  • [31] ADRIAMYCIN - AMELIORATION OF TOXICITY BY ALPHA-TOCOPHEROL
    MYERS, CE
    MCGUIRE, W
    YOUNG, R
    CANCER TREATMENT REPORTS, 1976, 60 (07): : 961 - 962
  • [32] TISSUE TOXICITY IN EXPERIMENTAL ISOLATED PERFUSION WITH ADRIAMYCIN
    HENNEKING, K
    AIGNER, K
    DEEG, C
    MERKER, G
    SPELZ, HW
    HUNDEIKER, M
    RECENT RESULTS IN CANCER RESEARCH, 1983, 86 : 254 - 259
  • [33] CHRONIC TOXICITY OF ADRIAMYCIN - NEW ANTINEOPLASTIC ANTIBIOTIC
    BERTAZZOLI, C
    FERNI, G
    SOLCIA, E
    RICEVUTI, G
    CHIELI, T
    TOXICOLOGY AND APPLIED PHARMACOLOGY, 1972, 21 (03) : 287 - +
  • [34] EFFECT OF KETOTIFEN ON ADRIAMYCIN TOXICITY - ROLE OF HISTAMINE
    KLUGMAN, FB
    DECORTI, G
    CANDUSSIO, L
    MALLARDI, F
    GRILL, V
    ZWEYER, M
    BALDINI, L
    CANCER LETTERS, 1988, 39 (02) : 145 - 152
  • [35] ROLE OF THE CARDIOLIPIN ADRIAMYCIN COMPLEX IN MITOCHONDRIAL TOXICITY
    GOORMAGHTIGH, E
    RUYSSCHAERT, JM
    COLLOIDS AND SURFACES, 1984, 10 (AUG): : 239 - 247
  • [36] Toxicity of magnetic albumin microspheres bearing adriamycin
    Ma Jianhua
    Chen Daoda
    Tian Yuan
    Tao Kaixiong
    Current Medical Science, 2000, 20 (3) : 261 - 262
  • [37] ADRIAMYCIN CARDIAC TOXICITY - POTENTIATION BY THORACIC RADIATION
    EWY, GA
    JONES, S
    YAUGER, H
    GROVES, B
    GAINES, J
    CLINICAL RESEARCH, 1976, 24 (02): : A120 - A120
  • [38] ADRIAMYCIN INDUCED INGESTIONAL AVERSION AND GASTROINTESTINAL TOXICITY
    BURHOLT, DR
    EDMONDS, K
    FEDERATION PROCEEDINGS, 1987, 46 (03) : 586 - 586
  • [39] Toxicity of Magnetic Albumin Microspheres Bearing Adriamycin
    马建华
    陈道达
    田源
    陶凯雄
    JournalofTongjiMedicalUniversity, 2000, (03) : 261 - 262
  • [40] ADRIAMYCIN TOXICITY - PRELIMINARY GUIDELINES FOR DOSAGE REDUCTION
    CHANG, P
    BRENNER, D
    MAURER, S
    RIGGS, C
    BACHUR, N
    WIERNIK, P
    CLINICAL RESEARCH, 1979, 27 (02): : A382 - A382